Specific inhibition of Candida albicans growth in vitro by antibodies from experimental Candida keratitis mice

Experimental Eye Research

Volumn 93, Issue 1, 2011, Pages 50-58

  Zhang, Hongbo ^a   Jia, Changkai ^a   Xi, Haijie ^a   Li, Siyuan ^a   Yang, Lingling ^a   Wang, Yiqiang ^a  

^a SHANDONG EYE INSTITUTE   (China)

Author keywords

Antibody dependent complement mediated cytotoxicity; Candida albicans; Fungal keratitis; Immunoglobulin; Immunopathology

Indexed keywords

ANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN; METHYLPREDNISOLONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; BAGG ALBINO MOUSE; CANDIDA ALBICANS; CONTROLLED STUDY; FUNGICIDAL ACTIVITY; FUNGUS GROWTH; FUNGUS SPORE; GROWTH INHIBITION; HISTOLOGY; HUMORAL IMMUNITY; IN VITRO STUDY; INFLAMMATORY CELL; KERATOMYCOSIS; LEUKOCYTE; MOUSE; NONHUMAN; PATHOGEN LOAD; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ANTIBODIES, FUNGAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CANDIDA ALBICANS; CANDIDIASIS; COLONY-FORMING UNITS ASSAY; CORNEA; CORNEAL ULCER; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE INFECTIONS, FUNGAL; IMMUNITY, HUMORAL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERFERON-GAMMA; INTERLEUKIN-4; LYMPHOCYTES; MICE; MICE, INBRED BALB C; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79960357724     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2011.04.010     Document Type: Article

References (22)

1. Ashman R.B., Farah C.S., Wanasaengsakul S., Hu Y., Pang G., Clancy R.L. Innate versus adaptive immunity in Candida albicans infection. Immunol. Cell. Biol. 2004, 82(2):196-204.
2. Baskova L., Landlinger C., Preuner S., Lion T. The Pan-AC assay: a single-reaction real-time PCR test for quantitative detection of a broad range of Aspergillus and Candida species. J. Med. Microbiol. 2007, 56(9):1167-1173.
3. Blanco J.L., Garcia M.E. Immune response to fungal infections. Vet. Immunol. Immunopathol. 2008, 125(1-2):47-70.
4. Casadevall A., Pirofski L.A. Antibody-mediated protection through cross-reactivity introduces a fungal heresy into immunological dogma. Infect. Immun. 2007, 75(11):5074-5078.
5. Cutler J.E., Deepe G.S., Klein B.S. Advances in combating fungal diseases: vaccines on the threshold. Nat. Rev. Microbiol. 2007, 5(1):13-28.
6. Dana M.R. Corneal antigen-presenting cells: diversity, plasticity, and disguise: the Cogan lecture. Invest. Ophthalmol. Vis. Sci. 2004, 45(3):722-727. 721.
7. Ha Y.-s., Covert S.F., Momany M. FsFKS1, the 1,3-{beta}-glucan synthase from the caspofungin-resistant fungus Fusarium solani. Eukaryotic Cell 2006, 5(7):1036-1042.
8. Hendricks R., Epstein R., Viana M., Hoffmann D. A reproducible method for injecting the mouse corneal stroma. Invest. Ophthalmol. Vis. Sci. 1991, 32(2):366-370.
9. Hodge W.G., Seiff S.R., Margolis T.P. Ocular opportunistic infection incidences among patients who are HIV positive compared to patients who are HIV negative. Ophthalmology 1998, 105(5):895-900.
10. Hohl T.M., Rivera A., Pamer E.G. Immunity to fungi. Curr. Opin. Immunol. 2006, 18(4):465-472.
11. Jin Y., Shen L., Chong E.M., Hamrah P., Zhang Q., Chen L., Dana M.R. The chemokine receptor CCR7 mediates corneal antigen-presenting cell trafficking. Mol. Vis. 2007, 13:626-634.
12. Mayer W.J., Irschick U.M., Moser P., Wurm M., Huemer H.P., Romani N., Irschick E.U. Characterization of antigen-presenting cells in fresh and cultured human corneas using novel dendritic cell markers. Invest. Ophthalmol. Vis. Sci. 2007, 48(10):4459-4467.
13. Mselle J. Fungal keratitis as an indicator of HIV infection in Africa. Trop. Doct. 1999, 29(3):133-135.
14. Nakai T., Uno J., Ikeda F., Tawara S., Nishimura K., Miyaji M. In vitro antifungal activity of Micafungin (FK463) against dimorphic fungi: comparison of yeast-like and mycelial forms. Antimicrob. Agents Chemother. 2003, 47(4):1376-1381.
15. Srinivasan M. Fungal keratitis. Curr. Opin. Ophthalmol. 2004, 15(4):321-327.
16. Tarabishy A.B., Aldabagh B., Sun Y., Imamura Y., Mukherjee P.K., Lass J.H., Ghannoum M.A., Pearlman E. MyD88 regulation of Fusarium keratitis is dependent on TLR4 and IL-1R1 but not TLR2. J. Immunol. 2008, 181(1):593-600.
17. Torosantucci A., Bromuro C., Chiani P., De Bernardis F., Berti F., Galli C., Norelli F., Bellucci C., Polonelli L., Costantino P., Rappuoli R., Cassone A. A novel glyco-conjugate vaccine against fungal pathogens. J. Exp. Med. 2005, 202(5):597-606.
18. Wozniak K.L., Wormley F.L., Fidel P.L. Candida-specific antibodies during experimental vaginal candidiasis in mice. Infect. Immun. 2002, 70(10):5790-5799.
19. Wu T.G., Wilhelmus K.R., Mitchell B.M. Experimental Keratomycosis in a mouse model. Invest. Ophthalmol. Vis. Sci. 2003, 44(1):210-216.
20. Xie L., Zhong W., Shi W., Sun S. Spectrum of fungal keratitis in north China. Ophthalmology 2006, 113(11):1943-1948.
21. Yuan X., Mitchell B.M., Wilhelmus K.R. Gene profiling and signaling pathways of Candida albicans keratitis. Mol. Vis. 2008, 14:1792-1798.
22. Zhang H., Chen H., Niu J., Wang Y., Xie L. Role of adaptive immunity in the pathogenesis of Candida albicans keratitis. Invest. Ophthalmol. Vis. Sci. 2009, 50(6):2653-2659.